About WellGen
WellGen, Inc. is a biotechnology company at the crossroads of foods and pharmaceuticals. Using the science of nutrigenomics, the company has developed Alignomxâ¢, a proprietary bioinformatics model that uses gene expression data to determine optimal therapeutic areas for WellGen's pipeline of proprietary natural products. Through its in-house expertise in nutrigenomics and natural product chemistry, WellGen is developing proprietary medical foods and has additionally identified several opportunities in the functional food and beverage and dietary supplement markets. WellGen is a portfolio company of Amphion Innovations (LSE: AMP).
|
|
|
1-10 employees
View all WellGen employees
|
|
Biotechnology Research
|
|
7325653896
|
|
North Brunswick, New Jersey
|
|
June
|
WellGen Alternatives
Frequently Asked Questions about WellGen
Andrea Stojanovic is the CEO of WellGen.
The decision makers in WellGen are Vandana Mistry, Andrea Stojanovic, Kathleen Mullinix, etc. Click to Find WellGen decision makers emails.
WellGen Staff Directory
Search WellGen Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
